LumiraDx Limited announced the appointment of Giffin Daughtridge as President, North America Commercial Operations, and Global Molecular Solutions, effective as of August 1, 2023. Peter Scheu, the previous President, North America Commercial Operations, resigned from his role effective August 1, 2023 but continues to support LumiraDx in an advisory capacity.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | +10.50% | -9.09% | -68.20% |
08/01 | Top Midday Decliners | MT |
08/01 | LumiraDx Limited(OTCPK:LMDX.F) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-68.20% | 6.49M | |
+13.28% | 227B | |
+13.92% | 192B | |
+17.79% | 136B | |
+28.39% | 108B | |
+1.67% | 64.07B | |
+17.50% | 52.1B | |
+7.04% | 51.87B | |
+10.83% | 44.33B | |
+5.61% | 36.75B |
- Stock Market
- Equities
- LMDXF Stock
- News LumiraDx Limited
- LumiraDx Limited Announces Executive Changes